Operator of a biopharmaceutical research company intended for the development process of biopharmaceutical drugs. The company specializes in formulation research and development of biopharmaceutical drugs and vaccines, and offers analytical services, including method development, qualification and validation, enabling clients to commercialize pharmaceutical products.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Operator of a biopharmaceutical company intended to create treatments for osteoarthritis. The company's product is an injectable biopharmaceutical gel-based therapeutic for the treatment of knee osteoarthritis (KOA) that integrates natural biopolymers with pharmacologically active agents, enabling healthcare professionals to tailor treatments for various chronic pain conditions while providing superior efficacy compared to existing treatments.
Manufacturer of pharmaceutical products and services intended to serve international health organizations, and public sectors. The company supplies several essential and lifesaving vaccines and pharmaceuticals and is committed to the prevention of hazards, risks and negative environmental impacts while developing, manufacturing, storing, handling and distributing its products, thereby enhancing mankind's ability to predict illness.